Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements
EJNMMI Radiopharmacy and Chemistry(2021)
摘要
In the frame of “precision medicine”, the scandium radionuclides have recently received considerable interest, providing personalised adjustment of radiation characteristics to optimize the efficiency of medical care or therapeutic benefit for particular groups of patients. Radionuclides of scandium, namely scandium-43 and scandium-44 ( 43/44 Sc) as positron emitters and scandium-47 ( 47 Sc), beta-radiation emitter, seem to fit ideally into the concept of theranostic pair. This paper aims to review the work on scandium isotopes production, coordination chemistry, radiolabeling, preclinical studies and the very first clinical studies. Finally, standardized procedures for scandium-based radiopharmaceuticals have been proposed as a basis to pave the way for elaboration of the Ph.Eur. monographs for perspective scandium radionuclides.
更多查看译文
关键词
Scandium radionuclides, Accelerator, and nuclear reactor production, Coordination, Radiolabeling, In vivo studies, Quality specifications
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要